CIK 0001885827
- Non-accelerated filer
- Emerging growth company
Virax Biolabs Group Ltd
Sign in to watch- Ticker
- VRAX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Mar 31
- Incorporated
- Cayman Islands
- Entity type
- Other
- Phone
- +44 2077887414
- Business address
- BIOCITY GLASGOW, BO'NESS ROAD, NEWHOUSE, LANARKSHIRE, United Kingdom, ML1 5UH
- Former names
- Virax Biolabs (Cayman) Ltd
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 20-F Report Annual and Transition Report of Foreign Private Issuers
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 20-F Report Annual and Transition Report of Foreign Private Issuers
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
Page 2 of 5 · 89 filings